Glenmark Life Sciences Limited
₹14,400(20 Shares)
Minimum Investment
IPO Dates
Jul 27, 2021 – Jul 29, 2021
Price Band
₹695–720 per equity share
Lot Size
20
Listing
Aug 6, 2021
Listing At
BSE, NSE
Glenmark Life Sciences Limited Live Subscription Details
All IPOsAll Live IPOsOverall Subscription
Total Bids Received
45.08x
Glenmark Life Sciences Limited IPO Issue Details
- Issue Price
- ₹695-720 Per Equity Share
- Face Value
- ₹2 Per Equity Share
- Listing At
- BSE, NSE
- Listing Date
- Aug 6, 2021
Company Information
Glenmark Life Sciences is the leading manufacturer of Active Pharmaceutical Ingredients (APIs). The company develops, manufactures, and supplies high-quality APIs for cardiovascular disease (CVS), cen...
Valuations
RoNW
46.71%
Financial Information (₹ in Crores)
* All figures are in ₹ Crores unless otherwise stated.
Objectives of the Issue
- 1To make payment of outstanding purchase consideration to the promoter for the spin-off of the API business from the promoter into the company.
- 2To finance capital expenditure requirements.
- 3To meet general corporate purposes.
Glenmark Life Sciences Limited – Promoter(s)
Contact Details
Glenmark Life Sciences Limited IPO Documents
Frequently Asked Questions — Glenmark Life Sciences Limited IPO
The Glenmark Life Sciences Limited IPO price band is set at ₹695.00 to ₹720.00 per equity share.
The lot size for Glenmark Life Sciences Limited IPO is 20 shares per lot. The minimum investment amount is approximately ₹14,400.
The Glenmark Life Sciences Limited IPO opens on Jul 27, 2021 and closes on Jul 29, 2021.
Glenmark Life Sciences Limited IPO is expected to be listed on Aug 6, 2021 on BSE, NSE.
